Prothena Corporation plc (0Y3M.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 06:37PM BST
| Previous close | 25.37 |
| Open | 25.67 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 24.20 - 25.67 |
| 52-week range | 24.20 - 79.15 |
| Volume | |
| Avg. volume | 345 |
| Market cap | 789.707M |
| Beta (5Y monthly) | 0.20 |
| PE ratio (TTM) | 0.18 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration
DUBLIN, May 28, 2024--Prothena today announced that Bristol Myers Squibb obtained the exclusive global license for PRX019 and will pay Prothena $80 million.
- Business Wire
Prothena Reports First Quarter 2024 Financial Results and Business Highlights
DUBLIN, May 08, 2024--Prothena today reported financial results for the first quarter of 2024 and provided business highlights
- Business Wire
Prothena to Report First Quarter 2024 Financial Results on May 8
DUBLIN, Ireland, May 01, 2024--Prothena announced that it will report first quarter 2024 financial results on Wednesday, May 8, 2024, after the close of the U.S. financial markets.
© 2024 Yahoo. All rights reserved.